s20098 has been researched along with Acute Confusional Senile Dementia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, F; Wang, J; Wang, Z; Yang, S; Zheng, B | 1 |
| Li, HH; Li, PP; Li, XX; Liu, ZL; Ren, C; Sun, X; Tao, S; Yao, XY | 1 |
| Atanasova, D; Atanasova, M; Ilieva, K; Kortenska, L; Tchekalarova, J | 2 |
| Yao, K; Zhao, YF; Zu, HB | 1 |
1 review(s) available for s20098 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.
Topics: Acetamides; Alzheimer Disease; Behavioral Symptoms; Humans; Receptors, Serotonin, 5-HT2 | 2021 |
4 other study(ies) available for s20098 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
The protective effects of Agomelatine against Aβ1-42 oligomers-induced cellular senescence mediated by SIRT6 and Agomelatine's potential in AD treatment.
Topics: Acetamides; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents; Antioxidants; Cells, Cultured; Cellular Senescence; Humans; Molecular Targeted Therapy; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Sirtuins | 2021 |
Chronic agomelatine treatment alleviates icvAβ-induced anxiety and depressive-like behavior through affecting Aβ metabolism in the hippocampus in a rat model of Alzheimer's disease.
Topics: Acetamides; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anxiety; Disease Models, Animal; Hippocampus; Rats | 2021 |
Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats.
Topics: Acetamides; Alzheimer Disease; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Exploratory Behavior; Hippocampus; Male; Maze Learning; Melatonin; Memory Disorders; Rats; Rats, Sprague-Dawley; Streptozocin | 2019 |
Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells.
Topics: Acetamides; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antidepressive Agents; Cell Survival; Malondialdehyde; Oxidative Stress; PC12 Cells; Peptide Fragments; Phosphorylation; Rats; Receptors, Melatonin; tau Proteins; Tryptamines | 2019 |